Further metabolic dysregulation was detected as an upregulation in IGFBP6 in schizophrenia and a decrease in IGF2 and IGFBP3/5/7/ALS (Fig. 2e). The gene discussed is IGF2; the disease is amyotrophic lateral sclerosis.